A Multicenter Phase II Trial of Ruxolitinib for Treatment of Corticosteroid Refractory Sclerotic Chronic Graft-Versus-Host Disease. Article (Faculty180)

cited authors

  • Kumar, Virender

authors

publication date

  • 2024

published in